This is a list of all the questions and their associated study carrel identifiers. One can learn a lot of the "aboutness" of a text simply by reading the questions.
| identifier | question |
|---|---|
| cord-254580-nhpjvgt4 | Coronavirus COVID-19 Global Cases by the Cross- Country Comparison of Case Fatality Rates of COVID Sleep disturbances in adults with eczema are associated with impaired overall health: a US population- based study National Health and Nutrition Examination Surveys Atopic dermatitis and psoriasis: two different immune diseases or one spectrum? |
| cord-255583-kgph7lr8 | Clinical features of patients infected with 2019 novel coronavirus in Wuhan COVID-19 and psoriasis: is it time to limit treatment with immunosuppressants? |
| cord-255583-kgph7lr8 | key: cord-255583-kgph7lr8 authors: Kutlu, Ömer; Metin, Ahmet title: A case of exacerbation of psoriasis after oseltamivir and hydroxychloroquine in a patient with COVID‐19: Will cases of psoriasis increase after COVID‐19 pandemic? |
| cord-265052-hfuvm1oh | What it whispers to us? |
| cord-265052-hfuvm1oh | what next? |
| cord-265052-hfuvm1oh | what next? |
| cord-274090-eab7i4f6 | : cord-274090-eab7i4f6 authors: Gaspari, Valeria; Lanzoni, Anna; Patrizi, Annalisa; Orioni, Gionathan; Viviani, Filippo; Bardazzi, Federico title: Can Covid‐19 be a sexually transmitted disease? |
| cord-277693-6lrawta5 | What does androgenetic alopecia have to do with COVID-19? |
| cord-263882-s5oxr6es | A child confirmed COVID-19 with only symptoms of conjunctivitis and eyelid dermatitis Characterizing the adverse dermatologic effects of hydroxychloroquine: a systematic review A case of exacerbation of psoriasis after oseltamivir and hydroxychloroquine in a patient with COVID-19: Will cases of psoriasis increase after COVID-19 pandemic? |
| cord-263882-s5oxr6es | CEBD: Centre of Evidence Based Dermatology Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases Cutaneous manifestations in COVID-19: a new contribution Cutaneous lesions in a patient with COVID-19: are they related? |
| cord-263882-s5oxr6es | COVID-19 can present with a rash and be mistaken for dengue Varicella- like exanthem as a specific COVID-19-associated skin manifestation: multicenter case series of 22 patients Varicella- like exanthem associated with COVID-19 in an 8-year- old girl: A diagnostic clue? |
| cord-263882-s5oxr6es | For consensus and more exact expert recommendations in this group of patients, we need data gathering about people who were in this situation and know more about what experience say about dermatologic disease course, COVID-19 course and manner of managing both conditions in the best possible way? |
| cord-263882-s5oxr6es | Najar Nobar, Niloufar; Goodarzi, Azadeh title: Patients with specific skin disorders who are affected by COVID‐19: what do experiences say about management strategies?: |
| cord-305076-v56y5nyt | where do KyberSept and SCARLET leave us? |
| cord-287013-9lgg5gya | Nonpharmaceutical measures for pandemic influenza in nonhealthcare settings- personal protective and environmental measures Association between atopic dermatitis and serious cutaneous, multiorgan and systemic infections in US adults Risks for infection in patients with asthma( or other atopic conditions): is asthma more than a chronic airway disease? |
| cord-287013-9lgg5gya | Rational use of face masks in the COVID-19 pandemic Australian government releases face masks to protect against coronavirus Mask crisis during the COVID-19 outbreak Covid-19: should the public wear face masks? |
| cord-302571-vb9ks4mq | Why tocilizumab could be an effective treatment for severe COVID-19? |
| cord-284158-5qvq27hu | A first step in understanding SARS pathogenesis Effects of oral ısotretinoin on normal and wounded nasal mucosa: an experimental study Effect of systemic isotretinoin therapy on mucociliary clearance and nasal surface mucosa in acne patients Consensus of Chinese experts on protection of skin and mucous membrane barrier for health- care workers fighting against coronavirus disease 2019 Evaluation of nasal Mucociliary clearance, nasal obstruction symptom evaluation, and epistaxis severity score in isotretinoin treatment CoV-2: olfaction, brain infection, and the urgent need for clinical samples allowing earlier virus detection Olfactory and gustatory dysfunctions as a clinical presentation of mild- to- moderate forms of the coronavirus disease( COVID-19): a multicenter European study Olfactory and gustatory dysfunction in depression: could it be a marker of folate deficiency? |
| cord-307000-mc5tpnbj | /acne inversa: a practical framework for treatment optimization-systematic review and recommendations from the HS ALLIANCE working group Novel therapeutic approaches and targets for treatment of Suppurativa Hidradenitis Induction of pro- inflammatory cytokines( IL-1 and IL-6) and lung inflammation by Coronavirus-19( COVI-19 or SARS- CoV-2): anti- inflammatory strategies COVID-19 and psoriasis: Is it time to limit treatment with immunosuppressants? |
| cord-276549-r5l4pse8 | Are erythema multiforme and urticaria related to a better outcome of COVID‐19? date: 2020- 06- 09 journal: |
| cord-296128-kjoi54ea | Giulia title: Do we have serological evidences that chilblain‐like lesions are related to SARS‐CoV‐2? |
| cord-296128-kjoi54ea | No Antibody Response in Acral Cutaneous Manifestations Associated With COVID-19? |
| cord-297295-lsewt5t2 | reduce pressure injury Absence of consequential changes physiological, thermal and subjected responses from wearing a surgical mask Covid-19: should the public wear face masks? |
| cord-280774-r2xm164s | A case report with histopathologic findings COVID-19 a proteiform disease inducing also molecular mimicry phenomena? |
| cord-280774-r2xm164s | The Columbus'egg? |
| cord-280774-r2xm164s | Why some children who come into contact with the SARS- CoV-2 do not develop striking respiratory symptoms but present pernio- like lesions with negativity on diagnostic tests? |
| cord-307925-0nhsf90c | : What should we expect? |
| cord-295995-uabnyomr | 19 Virus Be Transmitted Through Sex? |
| cord-295995-uabnyomr | Can Covid-19 Be a Sexually Transmitted Disease? |
| cord-270951-6nq3jwgr | COVID-19 and psoriasis: is it time to limit treatment with immunosuppressants? |
| cord-270951-6nq3jwgr | COVID‐19 and psoriasis: Should we fear for patients treated with biologics? |
| cord-270951-6nq3jwgr | Coronaviruses post- SARS: update on replication and pathogenesis MERS- CoV infection in humans is associated with a pro- inflammatory Th1 and Th17 cytokine profile Identification of common biological pathways and drug targets across multiple respiratory viruses based on human host gene expression analysis Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study Clinical and laboratory findings of SARS in Singapore Drug repurposing for viral infectious diseases: how far are we? |
| cord-270951-6nq3jwgr | Francesca Prignano https://orcid.org/0000-0002-5997-2045 Evaluation and Treatment Coronavirus( COVID-19) COVID-19 Coronavirus pandemic Immunogenicity of anti- TNFα therapy in psoriasis: a clinical issue? |
| cord-270951-6nq3jwgr | How should we treat them during COVID-19 pandemic? |
| cord-270951-6nq3jwgr | Should we fear for our psoriasis patients treated with biologicals? |
| cord-270951-6nq3jwgr | The facts during the third epidemic Successful recovery of COVID-19 pneumonia in a renal transplant recipient with long- term immunosuppression Expressive suppression and negative affect, pathways of emotional dysregulation in psoriasis patients PSOCUBE, a multidimensional assessment of psoriasis patients as a both clinically/ practically sustainable and evidence- based algorithm COVID-19 and psoriasis: Should we fear for patients treated with biologics? |
| cord-270951-6nq3jwgr | The origin, transmission and clinical therapies on coronavirus disease 2019( COVID-19) outbreak-an update on the status Comment on"COVID-19 and psoriasis: is it time to limit treatment with immunosuppressants? |
| cord-270951-6nq3jwgr | What about patients with inflammatory conditions? |
| cord-270951-6nq3jwgr | from Wuhan, China Clinical features of severe pediatric patients with coronavirus disease 2019 in Wuhan: a single center's observational study New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? |
| cord-293711-qgefn164 | COVID-19 and psoriasis: is it time to limit treatment with immunosuppressants? |
| cord-293711-qgefn164 | Is it time to limit treatment with immunosuppressants? |
| cord-293711-qgefn164 | Should biologics for psoriasis be interrupted in the era of COVID-19? Anti- HCV, nucleotide inhibitors, repurposing against COVID-19 No association between whole- body UVA1 phototherapy and skin cancers in humans |
| cord-296022-yl3j2x5p | How is the world responding to the 2019 coronavirus disease compared with the 2014 west African Ebola epidemic? |
| cord-289819-1kji8bbn | How do I communicate with doctors, nurses, and staff at the hospital during COVID-19? |
| cord-319820-eb5y7gxj | The enhanced preventive precautions for hand hygiene by using antiseptics, cologne, liquid soap allows patients to deal The effect of the"stay- athome"policy on requests for dermatology outpatient clinic visits after the COVID-19 outbreak Evaluation of dermatology consultations ın the era of COVID19 Dermatological diseases presented before COVID-19: Are patients with psoriasis and superficial fungal infections more vulnerable to the COVID-19? |
| cord-317323-wp3vh4c1 | For health professionals Aerosol filtration efficiency of common fabrics used in respiratory cloth masks Hair care during COVID-19: practical tips for health care workers To PAPR or not to PAPR? |
| cord-297400-l8fhy1hu | selfinflicted genital injury Dermatitis artefacta: psychological and neurological distress? |
| cord-334933-br1cr8kj | 10 Mohamad Goldust 7,11,12 1 World Health Organization declares global emergency: a review of the 2019 novel coronavirus( COVID-19) COVID-19: what is next for public health? |
| cord-324794-h08uzro4 | Dermatol Ther Dermatological diseases presented before COVID-19: Are patients with psoriasis and superficial fungal infections more vulnerable to the COVID-19? |
| cord-324794-h08uzro4 | Priorities for global health community in COVID-19 pandemic A case of exacerbation of psoriasis after oseltamivir and hydroxychloroquine in a patient with COVID-19: Will cases of psoriasis increase after COVID-19 pandemic? |
| cord-322332-0pi3wcv5 | ( COVID-19): facts and controversies Priorities for global health community in COVID-19 pandemic COVID-19 and psoriasis: is it time to limit treatment with immunosuppressants? |
| cord-335104-8b2tpbsh | : Is there a role for Interleukin 17? |
| cord-335104-8b2tpbsh | COVID-19: a case for inhibiting IL-17? |
| cord-320929-8h44wf36 | A boon or a bane? |
| cord-320929-8h44wf36 | During the Covid-19 Crisis Will Virtual Teaching Continue After the COVID-19 Pandemic? |
| cord-320929-8h44wf36 | The fate of major dermatology conferences and meetings of 2020; Are e- conferences and digital learning the future? |
| cord-328718-j9p7ahl8 | The Lancet Oncology Virtually perfect? |
| cord-320862-ua69gcxv | What is the role of a dermatologist in the battle against COVID-19? |
| cord-279056-mmcoqtb5 | 2 Infection SARS- CoV-2 infection presenting as a febrile rash Varicella- like exanthem associated with COVID-19 in an 8-year- old girl: A diagnostic clue? |
| cord-279056-mmcoqtb5 | : Is it time to limit treatment with immunosuppressants? |
| cord-279056-mmcoqtb5 | : Is it time to limit treatment with immunosuppressants? |
| cord-279056-mmcoqtb5 | : what do we know? |
| cord-279056-mmcoqtb5 | An Assessment of United States Dermatology Practices during the COVID-19 Outbreak Teledermatology: a useful tool to fight COVID-19 Cutaneous Side- Effects of the Potential Covid-19 Drugs Potential of chloroquine and hydroxychloroquine to treat COVID-19 causes fears of shortages among people with systemic lupus erythematosus Cutaneous manifestations in COVID-19: a new contribution Urticarial eruption in COVID-19 infection Cutaneous lesions in a patient with COVID-19: are they related? |
| cord-279056-mmcoqtb5 | COVID-19 and psoriasis: should we fear for patients treated with biologics? |
| cord-279056-mmcoqtb5 | Cutaneous manifestations in COVID-19: a first perspective Characterization of acute acro- ischemic lesions in non- hospitalized patients: a case series of 132 patients during the COVID-19 outbreak Clinical and Histopathological study of skin dermatoses in patients affected by COVID-19 infection in the Northern part of Italy Chilblain- like lesions during COVID-19 epidemic: a preliminary study on 63 patients Cutaneous manifestations in COVID-19: a first perspective"by Recalcati S Varicella- like exanthem as a specific COVID-19-associated skin manifestation: multicenter case series of 22 patients Acral cutaneous lesions in the Time of COVID-19 A case of exacerbation of psoriasis after oseltamivir and hydroxychloroquine in a patient with COVID-19: Will cases of psoriasis increase after COVID-19 pandemic? |
| cord-279056-mmcoqtb5 | Pediatric dermatology Azithromycin induced bullous fixed drug eruption Adverse effects of antiretroviral treatment Dermatology patients'knowledge and concerns regarding their immunomodulatory medication during the COVID-19 pandemic Mass quarantine measures in the time of COVID-19 pandemic: psycho- social implications for chronic skin conditions and a call for qualitative studies Potential role of Janus kinase inhibitors in COVID-19 Should SARS- CoV-2 influence immunosuppressive therapy for autoimmune blistering diseases? |
| cord-338135-zwo7e7gy | A case of exacerbation of psoriasis after oseltamivir and hydroxychloroquine in a patient with COVID-19: Will cases of psoriasis increase after COVID-19 pandemic? |
| cord-318866-3arxrm8m | Should biologics for psoriasis be interrupted in the era of COVID-19? |
| cord-355354-1zwgjfc7 | A common response to skin trauma Stratum corneum structure and function correlates with phenotype in psoriasis Are newly discovered drivers of immune- mediated skin disorders expressed in normal skin regenerating from standardized surface injury? |
| cord-348430-8xk4dt7t | A call for action Should biologics for psoriasis be interrupted in the era of COVID-19? |
| cord-348430-8xk4dt7t | COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome? |
| cord-348430-8xk4dt7t | Female patients are less satisfied with biological treatment for psoriasis and experience more side- effects than male patients: results from the prospective BioCAPTURE registry COVID-19 and psoriasis: is it time to limit treatment with immunosuppressants? |
| cord-348430-8xk4dt7t | Medication adherence: WHO cares? |
| cord-340029-iv2x1vap | : Is it time to limit treatment with immunosuppressants? |
| cord-343739-t3z6ghyp | Coronavirus disease 2019( COVID-19): facts and controversies COVID-19 and psoriasis: is it time to limit treatment with immunosuppressants? |
| cord-290137-3jyhc63d | a meta- analysis Is the Hospital Anxiety and Depression Scale( HADS) a valid measure in a general population 65- 80 years old? |
| cord-315166-ga6e3lqp | Online ahead of print Which are the"emergent"dermatologic practices during COVID-19 pandemic? |
| cord-305966-a61v2615 | The reality and challenges Statins: Could an old friend help the fight against COVID-19? |
| cord-336384-sollv92j | Torello title: What does androgenetic alopecia have to do with COVID‐19? |
| cord-323965-6mzzibj8 | Could Air Filtration Reduce COVID-19 Severity and Spread? |
| cord-323965-6mzzibj8 | How do we leave lockdown? |
| cord-323965-6mzzibj8 | a rapid qualitative evidence synthesis What are we doing in the dermatology outpatient department amidst the raging of the 2019 novel coronavirus? |
| cord-348846-mfhxac5c | COVID-19 and psoriasis: is it time to limit treatment with immunosuppressants? |
| cord-337382-b3wd182c | : should we really worry? |
| cord-337382-b3wd182c | Did Whatsapp ® reveal a new cutaneous COVID-19 manifestation? |